EVEREST ORGANICS
Back to Income Statement
|
EVEREST ORGANICS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹159 Cr | ₹197 Cr | ₹183 Cr | ₹200 Cr | ₹182 Cr |
What is the latest Revenue of EVEREST ORGANICS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹159 Cr |
| Mar2024 | ₹197 Cr |
| Mar2023 | ₹183 Cr |
| Mar2022 | ₹200 Cr |
| Mar2021 | ₹182 Cr |
How is Revenue of EVEREST ORGANICS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹159 Cr | -19.15 | |
| Mar2024 | ₹197 Cr | 7.75 | |
| Mar2023 | ₹183 Cr | -8.50 | |
| Mar2022 | ₹200 Cr | 10.18 | |
| Mar2021 | ₹182 Cr | - | |
Compare Revenue of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹225.8 Cr | -7% | -18.2% | -40.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -7% |
-18.2% |
-40.6% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses